tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

TFFP Stock Latest News

TFF Pharmaceuticals announces data from TFF TAC Phase 2 trial
The FlyTFF Pharmaceuticals announces data from TFF TAC Phase 2 trial
4d ago
TFFP
TFF Pharmaceuticals files to sell common stock, warrants, no amount given
PremiumThe Fly
TFF Pharmaceuticals files to sell common stock, warrants, no amount given
11d ago
TFFP
TFF Pharmaceuticals price target lowered to $13 from $25 at JonesResearch
PremiumThe Fly
TFF Pharmaceuticals price target lowered to $13 from $25 at JonesResearch
15d ago
TFFP
TFF Pharmaceuticals reports Q4 EPS ($2.01) vs. ($6.13) last year
PremiumThe Fly
TFF Pharmaceuticals reports Q4 EPS ($2.01) vs. ($6.13) last year
22d ago
TFFP
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
PremiumPress Releases
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
22d ago
TFFP
TFF Pharmaceuticals price target lowered to $44 from $56 at Roth MKM
PremiumThe FlyTFF Pharmaceuticals price target lowered to $44 from $56 at Roth MKM
22d ago
TFFP
TFF Pharmaceuticals Shares Key Updates with Investors
PremiumCompany Announcements
TFF Pharmaceuticals Shares Key Updates with Investors
23d ago
8K
TFFP
TFF Pharmaceuticals to present late-breaking abstract/data at ISHLT 2024
PremiumThe Fly
TFF Pharmaceuticals to present late-breaking abstract/data at ISHLT 2024
23d ago
TFFP
TFF Pharmaceuticals Announces Updated Data from the Tacrolimus Inhalation Powder (TFF TAC) and Voriconazole Inhalation Powder (TFF VORI) Clinical Programs
PremiumPress Releases
TFF Pharmaceuticals Announces Updated Data from the Tacrolimus Inhalation Powder (TFF TAC) and Voriconazole Inhalation Powder (TFF VORI) Clinical Programs
23d ago
TFFP
TFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting
PremiumPress Releases
TFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting
25d ago
TFFP
TFF Pharmaceuticals Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
PremiumPress Releases
TFF Pharmaceuticals Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
28d ago
TFFP
TFF Pharmaceuticals trading resumes
PremiumThe Fly
TFF Pharmaceuticals trading resumes
30d ago
TFFP
TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
PremiumPress ReleasesTFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
30d ago
TFFP
TFF Pharmaceuticals announces $1.2M registered direct offering
PremiumThe Fly
TFF Pharmaceuticals announces $1.2M registered direct offering
30d ago
TFFP
TFF Pharmaceuticals trading halted, volatility trading pause
PremiumThe Fly
TFF Pharmaceuticals trading halted, volatility trading pause
30d ago
TFFP
TFF Pharmaceuticals announces update on clinical program
PremiumThe Fly
TFF Pharmaceuticals announces update on clinical program
30d ago
TFFP
TFF Pharmaceuticals Announces Update on Clinical Programs
PremiumPress Releases
TFF Pharmaceuticals Announces Update on Clinical Programs
30d ago
TFFP
TFF Pharmaceuticals to Participate in the 36th Annual Roth Conference – March 17-19, 2024
PremiumPress Releases
TFF Pharmaceuticals to Participate in the 36th Annual Roth Conference – March 17-19, 2024
1M ago
TFFP
TFF Pharmaceuticals trading resumes
PremiumThe Fly
TFF Pharmaceuticals trading resumes
2M ago
TFFP
TFF Pharmaceuticals trading halted, volatility trading pause
PremiumThe FlyTFF Pharmaceuticals trading halted, volatility trading pause
2M ago
TFFP
TFF Pharmaceuticals to present data from its Phase 2 trial of TFF VORI
PremiumThe Fly
TFF Pharmaceuticals to present data from its Phase 2 trial of TFF VORI
3M ago
TFFP
TFF Pharmaceuticals to Present Data from Phase 2 Trial of Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Invasive Pulmonary Aspergillosis at the 11th Advances Against Aspergillosis & Mucormycosis Conference 
PremiumPress Releases
TFF Pharmaceuticals to Present Data from Phase 2 Trial of Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Invasive Pulmonary Aspergillosis at the 11th Advances Against Aspergillosis & Mucormycosis Conference 
3M ago
TFFP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >